BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9370911)

  • 1. Antineutrophil cytoplasm antibodies and vasculitis.
    Nash MC; Dillon MJ
    Arch Dis Child; 1997 Sep; 77(3):261-4. PubMed ID: 9370911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determining the significance of antineutrophil cytoplasmic autoantibodies].
    Meyer O
    Presse Med; 1992 Sep; 21(29):1361-3. PubMed ID: 1454764
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
    J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of ANCA positivity.
    Edgar JD
    Ann Rheum Dis; 1996 Aug; 55(8):494-6. PubMed ID: 8774174
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential.
    Kallenberg CG; Brouwer E; Weening JJ; Tervaert JW
    Kidney Int; 1994 Jul; 46(1):1-15. PubMed ID: 7933826
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
    Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
    J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of antineutrophil cytoplasmic antibody testing.
    Schmitt WH; van der Woude FJ
    Curr Opin Rheumatol; 2004 Jan; 16(1):9-17. PubMed ID: 14673383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of antineutrophil cytoplasmic antibodies.
    Rus V; Handwerger BS
    Curr Rheumatol Rep; 2000 Oct; 2(5):383-9. PubMed ID: 11123087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification of systemic vasculatides].
    Guillevin L; Pagnoux C; Guilpain P
    Presse Med; 2007 May; 36(5 Pt 2):845-53. PubMed ID: 17408915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor antigen and adhesive molecules in Wegener's granulomatosis and microscopic polyangiitis.
    Becvar R; Paleckova A; Tesar V; Rychlik I; Masek Z
    Clin Rheumatol; 1997 May; 16(3):324-5. PubMed ID: 9184277
    [No Abstract]   [Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis.
    Mareen P; Van De Walle S; Bernaert P; Vanhouteghem H; Dierick J
    Acta Clin Belg; 2003; 58(3):193-200. PubMed ID: 12945480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.
    Ito-Ihara T; Muso E; Kobayashi S; Uno K; Tamura N; Yamanishi Y; Fukatsu A; Watts RA; Scott DG; Jayne DR; Suzuki K; Hashimoto H
    Clin Exp Rheumatol; 2008; 26(6):1027-33. PubMed ID: 19210866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic autoantibodies (ANCA) associated vasculitides--immunologic and clinical aspects.
    Schulz JI
    Bratisl Lek Listy; 1995 Oct; 96(10):520-2. PubMed ID: 8620321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polynuclear neutrophil anti-cytoplasmic antibodies or ANCA: current aspects].
    Noel LH; Hachicha J; Ayadi H; Ben Hmida M; Jlidi R; Jarraya A
    Tunis Med; 1995; 73(6-7):229-34. PubMed ID: 9506170
    [No Abstract]   [Full Text] [Related]  

  • 19. ANCA testing. New developments and clinical implications.
    Ahmed AE; Peter JB; Shoenfeld YY
    Clin Rev Allergy Immunol; 1998; 16(3):303-11. PubMed ID: 9773257
    [No Abstract]   [Full Text] [Related]  

  • 20. [ANCA (antineutrophil cytoplasm antibodies)].
    Katz S
    Acta Gastroenterol Latinoam; 1994; 24(1):61-3. PubMed ID: 8059593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.